UBS upgrades UNIQA Insurance Group stock rating to Neutral on positive management actions

UBS has upgraded UNIQA Insurance Group AG (VIE:UQA) from Sell to Neutral, raising its price target to EUR11.60 from EUR9.00. This upgrade is attributed to UNIQA's strong year-to-date performance, positive management actions to reduce leverage and solvency sensitivities, and the significant appreciation of its Strabag stake. UBS has increased its growth expectations for the Austrian insurer, anticipating potential further target upgrades following the upcoming half-year reporting on August 22.

Analysis

UBS has upgraded UNIQA Insurance Group AG (VIE:UQA) to Neutral from Sell, increasing its price target to EUR11.60 from EUR9.00. The revision is underpinned by three primary factors: proactive management actions to de-risk the balance sheet by reducing leverage and solvency sensitivities, which has removed a previous valuation discount; strong first-quarter 2025 performance, prompting UBS to raise its forecasts for gross written premiums and earnings per share by 2 and 1 percentage points above management targets, respectively; and the significant, non-operating gain from UNIQA’s stake in Strabag, which has appreciated approximately 90% year-to-date. This upgrade comes after the stock has already delivered standout performance, rising about 50% YTD, placing it among the best in the European insurance sector. A key near-term catalyst is the upcoming half-year report on August 22, where UBS anticipates a potential upward revision of management's official targets.

Key Decisions for Investors

• Given the upgrade to Neutral from Sell and significant price target increase, investors should recognize that the bearish thesis has weakened considerably, warranting a re-evaluation of any short positions.
• The upcoming half-year report on August 22 is a key catalyst; monitor for a potential guidance upgrade from management, which could validate UBS's optimistic forecasts and support the stock's recent rally.
• Despite the positive fundamental shifts, the 'Neutral' rating suggests that after a 50% year-to-date gain, the improved outlook may be largely reflected in the current share price, advising a balanced hold rather than an aggressive buy.